Black Swan Sale

50% Off Elite

Register Now!

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Last Close
Nov 21  •  04:00PM ET
128.11
Dollar change
+4.14
Percentage change
3.34
%
IndexS&P 500 P/E16.07 EPS (ttm)7.97 Insider Own0.69% Shs Outstand1.74B Perf Week-1.90%
Market Cap222.77B Forward P/E22.61 EPS next Y5.67 Insider Trans-0.05% Shs Float1.73B Perf Month1.40%
Enterprise Value228.28B PEG1.56 EPS next Q1.50 Inst Own80.52% Short Float1.17% Perf Quarter-2.85%
Income13.89B P/S5.08 EPS this Y10.31% Inst Trans-0.56% Short Ratio3.41 Perf Half Y-2.43%
Sales43.84B P/B4.37 EPS next Y10.00% ROA17.53% Short Interest20.17M Perf YTD13.26%
Book/sh29.30 P/C28.81 EPS next 5Y10.30% ROE30.62% 52W High141.23 -9.29% Perf Year9.37%
Cash/sh4.45 P/FCF32.21 EPS past 3/5Y24.73% 29.98% ROIC22.21% 52W Low110.86 15.56% Perf 3Y23.65%
Dividend Est.2.38 (1.86%) EV/EBITDA20.67 Sales past 3/5Y-0.88% 5.63% Gross Margin52.09% Volatility3.21% 2.04% Perf 5Y12.70%
Dividend TTM2.36 (1.84%) EV/Sales5.21 EPS Y/Y TTM142.39% Oper. Margin18.05% ATR (14)2.85 Perf 10Y191.42%
Dividend Ex-DateOct 15, 2025 Quick Ratio1.24 Sales Y/Y TTM6.37% Profit Margin31.69% RSI (14)50.63 Recom1.73
Dividend Gr. 3/5Y7.17% 11.16% Current Ratio1.70 EPS Q/Q-2.54% SMA201.20% Beta0.70 Target Price145.38
Payout29.33% Debt/Eq0.25 Sales Q/Q6.90% SMA50-1.41% Rel Volume1.59 Prev Close123.97
Employees114000 LT Debt/Eq0.23 EarningsOct 15 BMO SMA200-2.26% Avg Volume5.91M Price128.11
IPOMar 01, 1937 Option/ShortYes / Yes EPS/Sales Surpr.-0.21% -0.18% Trades Volume9,375,239 Change3.34%
Date Action Analyst Rating Change Price Target Change
Oct-10-25Initiated The Benchmark Company Buy $145
Jul-18-25Upgrade Jefferies Hold → Buy $145
Jun-16-25Initiated Leerink Partners Market Perform $143
Oct-08-24Initiated Oppenheimer Outperform $130
Sep-19-24Initiated Piper Sandler Overweight $131
Jul-30-24Downgrade Edward Jones Buy → Hold
May-30-24Initiated Goldman Buy $121
Jul-21-23Upgrade Wolfe Research Underperform → Peer Perform
May-30-23Downgrade Morgan Stanley Overweight → Equal-Weight $112
Apr-20-23Reiterated Wolfe Research Underperform $107 → $103
Today 08:15AM
07:32AM
06:30AM
05:55AM
05:47AM
04:50AM Loading…
04:50AM
Nov-20-25 06:54PM
06:29PM
05:06PM
05:05PM
04:44PM
04:23PM
04:10PM
03:31PM
03:08PM
03:03PM Loading…
03:03PM
03:01PM
02:47PM
01:36PM
12:01PM
11:51AM
10:21AM
10:08AM
09:31AM
09:26AM
08:43AM
08:09AM
07:46AM
07:30AM
Nov-19-25 07:21PM
04:57PM Loading…
04:57PM
04:31PM
04:27PM
03:22PM
02:36PM
01:09PM
11:19AM
09:00AM
07:25AM
Nov-18-25 09:29AM
Nov-15-25 06:15PM
Nov-14-25 11:30AM
07:18AM
Nov-13-25 02:46PM
12:06PM
Nov-12-25 12:52PM
09:10AM
06:53AM
Nov-11-25 04:07PM
01:35PM
Nov-10-25 07:30AM
Nov-08-25 01:10PM
Nov-06-25 07:05AM
Nov-05-25 09:20AM
09:00AM
Nov-04-25 09:00AM
Nov-03-25 10:32PM
Nov-02-25 09:21PM
Nov-01-25 12:35PM
Oct-31-25 04:01PM
09:02AM
Oct-30-25 09:23AM
09:06AM
08:38AM
05:26AM
Oct-29-25 04:53PM
Oct-28-25 10:36AM
06:26AM
Oct-26-25 01:25PM
Oct-22-25 09:00AM
01:32AM
Oct-21-25 06:33AM
Oct-20-25 09:32AM
Oct-17-25 10:26AM
10:13AM
08:12AM
Oct-16-25 04:42PM
01:13PM
07:50AM
07:50AM
07:49AM
06:45AM
05:58AM
01:31AM
Oct-15-25 04:20PM
04:16PM
04:09PM
04:06PM
03:06PM
03:01PM
02:10PM
01:43PM
12:15PM
11:40AM
11:18AM
10:57AM
10:33AM
10:12AM
09:45AM
09:30AM
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Boudreau Philip PEVP AND CFOAug 08 '25Sale134.555,550746,75851,003Aug 11 05:53 PM
Boudreau Philip POfficerAug 08 '25Proposed Sale134.555,550746,758Aug 08 06:30 PM
Blount Sally E.DirectorApr 30 '25Sale129.662,600337,11634,058May 02 05:04 PM
SALLY E BLOUNTDirectorApr 30 '25Proposed Sale129.662,600337,116Apr 30 04:23 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 06 '25Option Exercise80.9891,1677,382,704163,095Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 07 '25Option Exercise80.9820016,19672,128Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 06 '25Sale133.8291,16712,199,96871,928Mar 07 06:55 PM
Earnhardt Lisa DEVP AND GROUP PRESIDENTMar 07 '25Sale136.6520027,32971,928Mar 07 06:55 PM
Lisa D. EarnhardtOfficerMar 07 '25Proposed Sale136.6520027,329Mar 07 06:28 PM
Lisa D. EarnhardtOfficerMar 06 '25Proposed Sale133.8291,16712,199,967Mar 06 05:47 PM
Wainer Andrea FRETIRED EVPMar 03 '25Sale138.17949131,12374,381Mar 04 08:05 PM
Shroff EricSenior Vice PresidentMar 03 '25Sale138.1756277,65231,970Mar 04 08:00 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTMar 03 '25Sale138.171,111153,50766,878Mar 04 07:49 PM
Moreland Mary KEXECUTIVE VICE PRESIDENTMar 03 '25Sale138.17791109,29295,583Mar 04 07:44 PM
MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLERMar 03 '25Sale138.1756277,65221,061Mar 04 07:39 PM
Eric ShroffOfficerMar 03 '25Proposed Sale138.1756277,651Mar 03 08:40 PM
Andrea F. WainerRetired OfficerMar 03 '25Proposed Sale138.17949131,123Mar 03 08:18 PM
Louis H. MorroneOfficerMar 03 '25Proposed Sale138.171,111153,506Mar 03 08:08 PM
Mary K. MorelandOfficerMar 03 '25Proposed Sale138.17791109,292Mar 03 07:58 PM
John A. McCoy, Jr.OfficerMar 03 '25Proposed Sale138.1756277,651Mar 03 07:52 PM
Ford Robert BCHAIRMAN AND CEOFeb 05 '25Option Exercise38.40285,38810,958,899505,447Feb 07 05:51 PM
Ford Robert BCHAIRMAN AND CEOFeb 05 '25Sale131.17285,38837,435,200220,059Feb 07 05:51 PM
Robert B. FordOfficerFeb 05 '25Proposed Sale131.17285,38837,435,238Feb 05 06:52 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 29 '25Option Exercise38.40131,3605,044,224316,166Jan 31 07:16 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 30 '25Option Exercise38.4058,4282,243,635243,234Jan 31 07:16 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 29 '25Sale128.35131,36016,859,675184,806Jan 31 07:16 PM
ALLEN HUBERT LEXECUTIVE VICE PRESIDENTJan 30 '25Sale128.0758,4287,482,629184,806Jan 31 07:16 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTJan 30 '25Option Exercise38.4023,771912,806149,468Jan 31 07:08 PM
Salvadori Daniel Gesua SiveEXECUTIVE VICE PRESIDENTJan 30 '25Sale128.5023,7713,054,574125,697Jan 31 07:08 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTJan 28 '25Sale127.392,644336,8190Jan 30 07:33 PM
Hubert L. AllenOfficerJan 30 '25Proposed Sale128.0758,4287,482,628Jan 30 05:33 PM
Daniel Gesua Sive SalvadoriOfficerJan 30 '25Proposed Sale128.5023,7713,054,573Jan 30 05:26 PM
Hubert L. AllenOfficerJan 29 '25Proposed Sale128.35131,36016,859,675Jan 29 05:30 PM